Ruxolitinib Cream Shows Promise for Hidradenitis Suppurativa

Treatment with the topical JAK inhibitor reduced abscess and inflammatory nodules in a phase 2 randomized, controlled trial in patients with mild hidradenitis suppurativa.

Related Keywords

United States ,California ,University Of Southern California ,Boston ,Massachusetts ,American ,Martinaj Porter ,P Jenniferl Hsiao ,Los Angeles ,Beth Israel Deaconess Medical Center ,Harvard Medical School ,American Academy Of Dermatology ,American Academy ,Southern California ,Hidradenitis Suppurativa ,Skin And Soft Tissue Infection ,Abscess ,Nodule ,Otolaryngology ,Nt Specialty ,Ead And Neck Surgery Ent Speciality ,Dermatoses ,Skin Disorders ,Skin Diseases ,Dermatitis ,Atopic Dermatitis ,Atopic Eczema ,Board Certification ,Boards ,Oard Recertification ,Common Cold ,Cute Nasopharyngitis ,Spain ,Pruritus ,Pruritis ,Pitch ,Topical Therapy ,Vitiligo ,